Chemoinformaics analysis of (Z)-3-Methyl-4-decenoic acid
| Molecular Weight | 184.279 | nRot | 7 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 2 |
| Exact Molecular Weight | 184.146 | nRing | 0 |
| Solubility: LogS | -3.081 | nHRing | 0 |
| Solubility: LogP | 3.788 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 33.3099 |
| nHD | 1 | BPOL | 20.9321 |
| QED | 0.487 |
| Synth | 2.873 |
| Natural Product Likeliness | 1.873 |
| NR-PPAR-gamma | 0.874 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.49 |
| MDCK | 0.000021 |
| BBB | 0.867 |
| PPB | 0.952662 |
| VDSS | 0.289 |
| FU | 0.0553473 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.679 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.83 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.973 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.204 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.077 |
| CL | 5.548 |
| T12 | 0.837 |
| hERG | 0.004 |
| Ames | 0.007 |
| ROA | 0.202 |
| SkinSen | 0.338 |
| Carcinogencity | 0.167 |
| EI | 0.992 |
| Respiratory | 0.147 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.730446 |